Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder

Scandinavian Journal of Urology and Nephrology

Volumn 45, Issue 6, 2011, Pages 388-392

  Jancke, Georg ^a   Rosell, Johan ^a   Jahnson, Staffan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

progression; recurrence; tumour size; urinary bladder cancer

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTINEOPLASTIC AGENTS; BCG VACCINE; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CLINICAL COMPETENCE; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 80955160146     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2011.590995     Document Type: Article

References (13)

1. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes A, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49: 466-77.
2. van Rhijn BWG, Burger M, Lotan L, Solsona E, Stief CG, Sylvester RJ, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy. Eur Urol 2009;56:430-42.
3. Ali-El-Dein B, Sarhan O, Hinev A, Ibrahiem EHI, Nabeeh A, Ghoneim MA. Superficial bladder tumours: Analysis of prognostic factors and construction of a predictive index. BJU Int 2003;92:393-9. (Pubitemid 37100517)
4. Zieger K, Wolf H, Olsen PR, Hojgaard K. Long term follow-up of noninvasive bladder tumours (stage Ta): Recurrence and progression. BJU Int 2000;85:824-8. (Pubitemid 30242785)
5. Rodriguez-Alonso A, Pita-Fernandez S, Gonzalez-Carrero J, Nogueira-March JL. Multivariate analysis of survival, recurrence, progression and development of metastasis in T1 and T2a transitional cell bladder carcinoma. Cancer 2002;94: 1677-84. (Pubitemid 34241104)
6. Parmar MKB, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors and follow-up policies in the treatment of superficial bladder cancer: Report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol 1989;142:284-8. (Pubitemid 19197097)
7. Reuter VE, Epstein JI, Amin MB, Mostafi FK. The WHO/ ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms. Hum Pathol 1999;30:879-80.
8. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
9. Babjuk M. Transurethral resection of non-muscle-invasive bladder cancer. Eur Urol Suppl 2009;8:542-8.
10. Gupta SK, Parr G, Parr NJ. Outcome of very large superficial tumours: A 10 year experience. Scand J Urol Nephrol 2008; 42:243-8. (Pubitemid 351574397)
11. Soloway MS, Bruck DS, Kim S. Expectant management of small, recurrent, noninvasive papillary bladder tumours. J Urol 2003;170:438-41. (Pubitemid 36870219)
12. Berrum-Svennung I, Granfors T, Jahnson S, Boman H, Holmäng S. A single instillation of epirubicin after transurethral resection of bladder tumours prevents only small recurrences. J Urol 2008;179:101-6. (Pubitemid 350225697)
13. Jancke G, Damm O, Rosell J, Jahnson S. Risk factors for local recurrence in pTa/pT1 urinary bladder cancer. Scand J Urol Nephrol 2008;42:417-21.